SB 206553 hydrochloride |
| Catalog No.GC10310 |
5-HT2B/5-HT2C receptor antagonist
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1197334-04-5
Sample solution is provided at 25 µL, 10mM.
Product has been cited by 1 publications
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
| Cas No. | 1197334-04-5 | SDF | |
| Chemical Name | (Z)-5-methyl-N-(pyridin-3-yl)-2,3-dihydropyrrolo[2,3-f]indole-1(5H)-carbimidic acid | ||
| Canonical SMILES | CN1C=CC2=CC3=C(C=C21)CCN3/C(O)=N/C4=CN=CC=C4 | ||
| Formula | C17H16N4O.HCl | M.Wt | 328.8 |
| Solubility | <32.88mg/ml in DMSO | Storage | Desiccate at RT |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
Complete Stock Solution Preparation Table
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 3.0414 mL | 15.2068 mL | 30.4136 mL |
| 5 mM | 0.6083 mL | 3.0414 mL | 6.0827 mL |
| 10 mM | 0.3041 mL | 1.5207 mL | 3.0414 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC38369 (±)-Leucine
- GC43666 Fingolimod
- GC61957 SU4984
- GC46188 Novobiocic Acid
- GC33422 HAT-IN-1
- GC42464 4-oxo-2-Nonenal
- GC13033 SB 611812
- GC45770 Prostaglandin D Synthase (hematopoietic-type) Inhibitor F092
- GC42688 Ac-DMQD-CHO (trifluoroacetate salt)
- GC36376 Kaempferol 3-O-sophoroside
- GC14699 CPI-203
- GC30340 SP-420
- GC30637 N-Methylmoranoline (MOR 14)
- GC19475 DPPH
- GC32418 Falintolol, (Z)-
- GC13441 Cyclopamine
Reviews
Average Rating: 5 ★★★★★ (Based on Reviews and 34 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *